| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A model for individualized risk prediction of contralateral breast cancer
|
Chowdhury, Marzana
|
|
2016
|
161 |
1 |
p. 153-160
|
artikel
|
| 2 |
A prospective study of peripheral blood DNA methylation at RPTOR, MGRN1 and RAPSN and risk of breast cancer
|
Dugué, Pierre-Antoine
|
|
2016
|
161 |
1 |
p. 181-183
|
artikel
|
| 3 |
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study
|
Harbeck, Nadia
|
|
2016
|
161 |
1 |
p. 63-72
|
artikel
|
| 4 |
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3
|
Hamdi, Yosr
|
|
2016
|
161 |
1 |
p. 117-134
|
artikel
|
| 5 |
Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy
|
Braunstein, Lior Z.
|
|
2016
|
161 |
1 |
p. 173-179
|
artikel
|
| 6 |
Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
|
Kotsopoulos, Joanne
|
|
2016
|
161 |
1 |
p. 11-16
|
artikel
|
| 7 |
Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors
|
Calip, Gregory S.
|
|
2016
|
161 |
1 |
p. 161-172
|
artikel
|
| 8 |
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast
|
Campbell, Michael J.
|
|
2016
|
161 |
1 |
p. 17-28
|
artikel
|
| 9 |
Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer
|
Amara, Dominic
|
|
2016
|
161 |
1 |
p. 41-50
|
artikel
|
| 10 |
3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study)
|
Merzenich, Hiltrud
|
|
2016
|
161 |
1 |
p. 143-152
|
artikel
|
| 11 |
Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
|
Kim, Haeyoung
|
|
2016
|
161 |
1 |
p. 95-102
|
artikel
|
| 12 |
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer
|
Wang, Chun
|
|
2016
|
161 |
1 |
p. 83-94
|
artikel
|
| 13 |
Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–cyclophosphamide chemotherapy for breast cancer: a systematic review
|
Fernandes, Ricardo
|
|
2016
|
161 |
1 |
p. 1-10
|
artikel
|
| 14 |
Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients
|
Janssen, Nicole
|
|
2016
|
161 |
1 |
p. 51-62
|
artikel
|
| 15 |
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis
|
Jankowski, Clémentine
|
|
2016
|
161 |
1 |
p. 73-81
|
artikel
|
| 16 |
Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel
|
Moran, Olivia
|
|
2016
|
161 |
1 |
p. 135-142
|
artikel
|
| 17 |
The impact of nodal micrometastasis on mortality among women with early-stage breast cancer
|
Iqbal, Javaid
|
|
2016
|
161 |
1 |
p. 103-115
|
artikel
|
| 18 |
Up-regulation of cathepsin S expression by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer
|
Gautam, Jaya
|
|
2016
|
161 |
1 |
p. 29-40
|
artikel
|
Tijdschrift beschrijving